Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study
No abstract is available for this record.
Bibliographic context
Authors
Sara EllisCatherine BostianWendy FengE. Grace FischerGarrett SchwartzKatherine EisenMelanie LeanElizabeth ConlanMichael J. OstacherScott T. AaronsonTrisha Suppes
Watch author
Topics and keywords
psilocybin DepressionChronic PainClinical TrialTreatment-Resistant DepressionVeteransToxicity Clinical Trial PsilocybinOpen labelDepression (economics)PsychiatryTreatment-resistant depressionPsychologyMedicinePsychotherapistMajor depressive disorderHallucinogenClinical trialInternal medicineMoodEconomicsMacroeconomicsPsychedelics and Drug StudiesForensic Toxicology and Drug AnalysisPain Management and Placebo Effect
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
No close related records were found yet.